AQR Capital Management
XBIT icon

AQR Capital Management’s XBiotech XBIT Stock Holding History

AQR Capital Management’s Portfolio XBIT Stock Details XBIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-29,365
Closed -$254K – 2310
2022
Q1 		$254K Sell
29,365
-39,282
-57% -$394K ﹤0.01% 2006
2021
Q4 		$764K Buy
68,647
+11,202
+20% +$146K ﹤0.01% 1677
2021
Q3 		$744K Buy
57,445
+26,741
+87% +$426K ﹤0.01% 1700
2021
Q2 		$508K Sell
30,704
-27,103
-47% -$460K ﹤0.01% 1894
2021
Q1 		$993K Sell
57,807
-3,279
-5% -$61.2K ﹤0.01% 1552
2020
Q4 		$956K Sell
61,086
-2,609
-4% -$48.1K ﹤0.01% 1524
2020
Q3 		$1.22M Sell
63,695
-14,807
-19% -$256K ﹤0.01% 1322
2020
Q2 		$1.08M Buy
78,502
+33,992
+76% +$478K ﹤0.01% 1434
2020
Q1 		$473K Buy
44,510
+16,655
+60% +$271K ﹤0.01% 1605
2019
Q4 		$520K Buy
27,855
+5,312
+24% +$68.4K ﹤0.01% 1737
2019
Q3 		$236K Buy
+22,543
New +$184K ﹤0.01% 1969

Other funds holding XBIT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
OMC
Oasis Management Company Grand Cayman, Cayman Islands $1.72B AUM 32.1% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

AQR Capital Management's XBIT Position: Q2 2022 in Review

AQR Capital Management sold out of XBiotech (XBIT) in Q2 2022, closing a stake of 29,365 shares — an estimated $254K sold.

AQR Capital Management first reported a position in XBIT in Q3 2019 and held it in 11 quarters. The position peaked at $1.22M in Q3 2020. 56 funds tracked by Wall St. Rank hold XBIT as of Q2 2022.

  • AQR Capital Management reported no remaining XBiotech position as of Q2 2022 after selling out during the quarter.
  • AQR Capital Management sold 29,365 XBiotech shares in Q2 2022, an estimated $254K.
  • AQR Capital Management first reported a position in XBiotech in Q3 2019 and held it in 11 quarters.
  • AQR Capital Management's XBiotech position peaked at $1.22M in Q3 2020.
  • 56 funds tracked by Wall St. Rank held XBiotech as of Q2 2022.

Based on AQR Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.